Citation
Serpente, Maria, et al. "MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles From Patients With Alzheimer's Disease." Cells, vol. 9, no. 6, 2020.
Serpente M, Fenoglio C, D'Anca M, et al. MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease. Cells. 2020;9(6).
Serpente, M., Fenoglio, C., D'Anca, M., Arcaro, M., Sorrentino, F., Visconte, C., Arighi, A., Fumagalli, G. G., Porretti, L., Cattaneo, A., Ciani, M., Zanardini, R., Benussi, L., Ghidoni, R., Scarpini, E., & Galimberti, D. (2020). MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease. Cells, 9(6). https://doi.org/10.3390/cells9061443
Serpente M, et al. MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles From Patients With Alzheimer's Disease. Cells. 2020 06 10;9(6) PubMed PMID: 32531989.
TY - JOUR
T1 - MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease.
AU - Serpente,Maria,
AU - Fenoglio,Chiara,
AU - D'Anca,Marianna,
AU - Arcaro,Marina,
AU - Sorrentino,Federica,
AU - Visconte,Caterina,
AU - Arighi,Andrea,
AU - Fumagalli,Giorgio G,
AU - Porretti,Laura,
AU - Cattaneo,Alessandra,
AU - Ciani,Miriam,
AU - Zanardini,Roberta,
AU - Benussi,Luisa,
AU - Ghidoni,Roberta,
AU - Scarpini,Elio,
AU - Galimberti,Daniela,
Y1 - 2020/06/10/
PY - 2020/04/29/received
PY - 2020/06/04/revised
PY - 2020/06/08/accepted
PY - 2020/6/14/entrez
PY - 2020/6/14/pubmed
PY - 2021/3/19/medline
KW - Alzheimer’s disease
KW - extracellular vesicles (EVs)
KW - microRNA
KW - neural-derived extracellular vesicles (NDEVs)
JF - Cells
JO - Cells
VL - 9
IS - 6
N2 - Small extracellular vesicles (EVs) are able to pass from the central nervous system (CNS) into peripheral blood and contain molecule markers of their parental origin. The aim of our study was to isolate and characterize total and neural-derived small EVs (NDEVs) and their micro RNA (miRNA) cargo in Alzheimer's disease (AD) patients. Small NDEVs were isolated from plasma in a population consisting of 40 AD patients and 40 healthy subjects (CTRLs) using high throughput Advanced TaqMan miRNA OpenArrays®, which enables the simultaneous determination of 754 miRNAs. MiR-23a-3p, miR-223-3p, miR-100-3p and miR-190-5p showed a significant dysregulation in small NDEVs from AD patients as compared with controls (1.16 ± 0.49 versus 7.54 ± 2.5, p = 0.026; 9.32 ± 2.27 versus 0.66 ± 0.18, p <0.0001; 0.069 ± 0.01 versus 0.5 ± 0.1, p < 0.0001 and 2.9 ± 1.2 versus 1.93 ± 0.9, p < 0.05, respectively). A further validation analysis confirmed that miR-23a-3p, miR-223-3p and miR-190a-5p levels in small NDEVs from AD patients were significantly upregulated as compared with controls (p = 0.008; p = 0.016; p = 0.003, respectively) whereas miR-100-3p levels were significantly downregulated (p = 0.008). This is the first study that carries out the comparison between total plasma small EV population and NDEVs, demonstrating the presence of a specific AD NDEV miRNA signature.
SN - 2073-4409
UR - https://www.unboundmedicine.com/medline/citation/32531989/MiRNA_Profiling_in_Plasma_Neural_Derived_Small_Extracellular_Vesicles_from_Patients_with_Alzheimer's_Disease_
DB - PRIME
DP - Unbound Medicine
ER -